BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

58.50 +1.15 (+2.01%)

Streaming Delayed Price Updated: 9:49 AM EDT, Jun 26, 2026 Add to My Watchlist

Price and Volume

Volume	170,325
Open	57.35
Bid (Size)	58.42 (100)
Ask (Size)	58.55 (100)
Prev. Close	57.35
Today's Range	57.35 - 58.72
52wk Range	49.26 - 66.28
Shares Outstanding	183,352,255
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off

Today 0:34 EDT

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...

Via StockStory

Therapeutics Stocks Q1 Teardown: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest

June 24, 2026

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...

Via StockStory

Performance

YTD	-1.6%	-1.6%
1 Month	+10.6%	+10.6%
3 Month	+5.3%	+5.3%
6 Month	-2.4%	-2.4%
1 Year	+8.1%	+8.1%

More News

2 Profitable Stocks Worth Your Attention and 1 We Find Risky

June 11, 2026

Via StockStory

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Decent Value Play with Strong Fundamentals ↗

June 10, 2026

Via Chartmill

What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year ↗

May 30, 2026

Via The Motley Fool

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Value Opportunity with Strong Fundamentals and Accelerating Growth ↗

May 19, 2026

Via Chartmill

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

May 21, 2026

Via StockStory

1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky

May 21, 2026

Via StockStory

2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down

May 14, 2026

Via StockStory

BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 11, 2026

Via StockStory

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q1 Earnings Miss Masked by Raised 2026 Guidance ↗

May 04, 2026

Via Chartmill

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Emerges as a Compelling Value Stock ↗

April 17, 2026

Via Chartmill

BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook

May 05, 2026

Via StockStory

BioMarin (BMRN) Q1 2026 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

BioMarin Pharmaceutical (NASDAQ:BMRN) Misses Q1 CY2026 Revenue Estimates

May 04, 2026

Via StockStory

BioMarin (BMRN) Q4 2025 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

BioMarin Pharmaceutical (BMRN) Reports Earnings Tomorrow: What To Expect

May 02, 2026

Via StockStory

Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity

April 13, 2026

Via MarketMinute

2 Profitable Stocks with Promising Prospects and 1 Facing Challenges

April 08, 2026

Via StockStory

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

April 02, 2026

Via StockStory

Ultragenyx Vaults Toward Commercialization as FDA Accepts Landmark Gene Therapy BLA

April 02, 2026

Via MarketMinute

1 of Wall Street’s Favorite Stock with Promising Prospects and 2 We Find Risky

March 26, 2026

Via StockStory

Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗

March 20, 2026

Via The Motley Fool

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position ↗

March 20, 2026

Via The Motley Fool

Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks

March 19, 2026

Via StockStory

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?

Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.

What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?

BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?

The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market

What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?

The current price of BioMarin Pharmaceutical Inc. - Common Stock is 58.50

When was BioMarin Pharmaceutical Inc. - Common Stock last traded?

The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 06/26/26 09:49 AM ET

What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?

The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.73B

How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?

BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.